Mutation at the catalytic site (M519V) in glycogen storage disease type II (Pompe disease)
Maryann L. Huie(Columbia University Irving Medical Center), Nan Zhong(New York State Office for People With Developmental Disabilities), Agnes S. Chen(New York University), Frank Martiniuk(Psychogenics (United States)), Rochelle Hirschhorn(New York University)
Cited by 17
Related Papers
A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1.
|Proceedings of the National Academy of Sciences|1992|730
STUDIES ON LYSOSOMES
|The Journal of Cell Biology|1968|234
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
|Clinical Cancer Research|2012|225
Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease
|American Journal of Medical Genetics|1998|214
Identification of two subtypes of infantile acid maltase deficiency
|The Journal of Pediatrics|2000|167